KENOTA
LIVE

Serial Number

88794131

Owner

Kenota Inc.

Attorney

Erika L. Jenkins, Esq.

First Use Date

Jan 5, 2023

Filing Date

Feb 12, 2020

Add to watchlist:

No watchlists yet
View on USPTO

KENOTA Trademark

Serial Number: 88794131 • Registration: 7089131

KENOTA is a trademark filed by Kenota Inc. on February 12, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Kenota Inc.

Kitchener, Ontario N2M5E1 , CA

Entity Type: 03

Trademark Details

Filing Date

February 12, 2020

Registration Date

June 27, 2023

First Use Anywhere

January 5, 2023

First Use in Commerce

January 5, 2023

Published for Opposition

April 11, 2023

Goods & Services

Computer hardware platform for use in medical diagnostics to treat allergies, infectious diseases, neurological disorders, cardiovascular diseases, skin disorders, cancers, and endocrine disorders, and to monitor general health biomarkers for medical and veterinary purposes

Transdermal patches for use in medical diagnostics to treat allergies, infectious diseases, neurological disorders, cardiovascular diseases, skin disorders, cancers, and endocrine disorders, and to monitor general health biomarkers for medical and veterinary purposes; transdermal patches for use in drug delivery and immunotherapy delivery applications to treat allergies, infectious diseases, neurological disorders, cardiovascular diseases, skin disorders, cancers, and endocrine disorders, and to monitor general health biomarkers for medical and veterinary purposes; biochemical assays for testing body fluids for use in medical diagnostics and point-of-care diagnostics for medical and veterinary purposes

Medical equipment in the nature of microfluidic testing systems, blood testing and analysis systems, lateral flow assay testing systems for use in medical diagnostics to treat allergies, infectious diseases, neurological disorders, cardiovascular diseases, skin disorders, cancers, and endocrine disorders, and to monitor general health biomarkers for medical and veterinary purposes; micro needles and finger-prick blood sample collection instruments for medical and veterinary purposes; medical devices, namely, lancets, syringes, blood collectors, cartridges, cartridge sleeves, for medical and veterinary purposes; medical devices for use in microfluidics, namely, paper-based microfluidics and microfluidic chips for medical and veterinary purposes; finger prick needles for medical and veterinary purposes

Medical device research and development services for medical and veterinary purposes; research and development services in the area of in vitro diagnostics (IVD) for medical and veterinary purposes; point-of-care medical device research and development services for medical and veterinary purposes; research and development services in the area of allergy testing for medical and veterinary purposes; research and development services in the area of transdermal pharmaceutical drug delivery for medical and veterinary purposes; research and development services in the area of transdermal immunotherapy delivery for medical and veterinary purposes; all of the aforementioned services being performed for others

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 27, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 27, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 11, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 11, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 22, 2023 NONP
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Mar 7, 2023 AAUA
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 6, 2023 CNSA
USE AMENDMENT ACCEPTED
Mar 6, 2023 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Feb 28, 2023 AUPC
USE AMENDMENT FILED
Feb 28, 2023 IUAF
TEAS AMENDMENT OF USE RECEIVED
Feb 27, 2023 EAAU
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 22, 2023 ERSI
ASSIGNED TO EXAMINER
Jan 17, 2023 DOCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 28, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 28, 2022 GNSL
SUSPENSION LETTER WRITTEN
Nov 28, 2022 CNSL
ASSIGNED TO EXAMINER
Oct 26, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 25, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2022 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 25, 2022 CHAN
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 25, 2022 ERSI
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 18, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 18, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 18, 2022 REAP
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 16, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 16, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 16, 2022 CNSI
ASSIGNED TO EXAMINER
Aug 12, 2022 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 29, 2022 RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 10, 2022 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 15, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 15, 2021 GNSL
SUSPENSION LETTER WRITTEN
Nov 15, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 10, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 10, 2021 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 10, 2021 CHAN
ASSIGNED TO LIE
Sep 10, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 2, 2021 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 16, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 16, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 16, 2021 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 4, 2021 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 4, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 4, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 4, 2021 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 28, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 28, 2020 GNSL
SUSPENSION LETTER WRITTEN
Oct 28, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 8, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 8, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 8, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 6, 2020 GNRN
NON-FINAL ACTION E-MAILED
May 6, 2020 GNRT
NON-FINAL ACTION WRITTEN
May 6, 2020 CNRT
ASSIGNED TO EXAMINER
May 2, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 18, 2020 NWOS
NEW APPLICATION ENTERED
Feb 15, 2020 NWAP